Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Breeze Holdings Acquisition Corp. stock logo
BREZ
Breeze Holdings Acquisition
$11.43
$10.38
$12.24
$48.98M0.03N/AN/A
Clene Inc. stock logo
CLNN
Clene
$3.77
+1.9%
$3.56
$2.28
$6.96
$30.59M0.5589,123 shs18,586 shs
Longevity Acquisition Co. stock logo
LOAC
Longevity Acquisition
$13.45
$12.99
$10.24
$19.25
$35.32M-0.0192,113 shs47,631 shs
Roth CH Acquisition II Co. stock logo
ROCC
Roth CH Acquisition II
$37.47
$9.01
$8.78
$11.58
$1.56B2.65477,953 shsN/A
Tottenham Acquisition I Limited stock logo
TOTA
Tottenham Acquisition I
$10.82
$10.97
$10.30
$17.50
$37.39M0.0536,696 shsN/A
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Breeze Holdings Acquisition Corp. stock logo
BREZ
Breeze Holdings Acquisition
0.00%0.00%0.00%0.00%0.00%
Clene Inc. stock logo
CLNN
Clene
+1.89%-1.57%-14.71%+25.67%-23.06%
Longevity Acquisition Co. stock logo
LOAC
Longevity Acquisition
0.00%0.00%0.00%0.00%0.00%
Roth CH Acquisition II Co. stock logo
ROCC
Roth CH Acquisition II
0.00%0.00%0.00%0.00%0.00%
Tottenham Acquisition I Limited stock logo
TOTA
Tottenham Acquisition I
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Breeze Holdings Acquisition Corp. stock logo
BREZ
Breeze Holdings Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Clene Inc. stock logo
CLNN
Clene
3.5729 of 5 stars
3.65.00.00.02.72.50.6
Longevity Acquisition Co. stock logo
LOAC
Longevity Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Roth CH Acquisition II Co. stock logo
ROCC
Roth CH Acquisition II
N/AN/AN/AN/AN/AN/AN/AN/A
Tottenham Acquisition I Limited stock logo
TOTA
Tottenham Acquisition I
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Breeze Holdings Acquisition Corp. stock logo
BREZ
Breeze Holdings Acquisition
0.00
N/AN/AN/A
Clene Inc. stock logo
CLNN
Clene
3.17
Buy$40.00961.01% Upside
Longevity Acquisition Co. stock logo
LOAC
Longevity Acquisition
0.00
N/AN/AN/A
Roth CH Acquisition II Co. stock logo
ROCC
Roth CH Acquisition II
0.00
N/AN/AN/A
Tottenham Acquisition I Limited stock logo
TOTA
Tottenham Acquisition I
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest TOTA, ROCC, BREZ, LOAC, and CLNN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/30/2025
Clene Inc. stock logo
CLNN
Clene
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$23.00
5/8/2025
Clene Inc. stock logo
CLNN
Clene
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$84.00 ➝ $33.00
5/8/2025
Clene Inc. stock logo
CLNN
Clene
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$23.00 ➝ $23.00
4/23/2025
Clene Inc. stock logo
CLNN
Clene
Jones Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$30.00
(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Breeze Holdings Acquisition Corp. stock logo
BREZ
Breeze Holdings Acquisition
N/AN/AN/AN/A($2.25) per shareN/A
Clene Inc. stock logo
CLNN
Clene
$350K89.05N/AN/A($1.06) per share-3.56
Longevity Acquisition Co. stock logo
LOAC
Longevity Acquisition
N/AN/AN/AN/A$0.92 per shareN/A
Roth CH Acquisition II Co. stock logo
ROCC
Roth CH Acquisition II
$1.15B1.36$16.51 per share2.27$25.40 per share1.48
Tottenham Acquisition I Limited stock logo
TOTA
Tottenham Acquisition I
N/AN/AN/AN/A$7.63 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Breeze Holdings Acquisition Corp. stock logo
BREZ
Breeze Holdings Acquisition
-$2.55MN/A0.00N/AN/AN/AN/A-181.15%N/A
Clene Inc. stock logo
CLNN
Clene
-$39.40M-$4.04N/AN/AN/A-8,306.00%N/A-105.11%8/6/2025 (Estimated)
Longevity Acquisition Co. stock logo
LOAC
Longevity Acquisition
-$290KN/AN/AN/AN/A-10.12%-1.43%N/A
Roth CH Acquisition II Co. stock logo
ROCC
Roth CH Acquisition II
$217.69M$13.822.713.65N/A24.39%43.26%21.78%N/A
Tottenham Acquisition I Limited stock logo
TOTA
Tottenham Acquisition I
$270KN/AN/AN/AN/A-1.14%-1.05%N/A

Latest TOTA, ROCC, BREZ, LOAC, and CLNN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Clene Inc. stock logo
CLNN
Clene
-$0.49N/AN/AN/A$0.06 millionN/A
5/7/2025Q1 2025
Clene Inc. stock logo
CLNN
Clene
-$1.10-$0.50+$0.60-$0.09$0.07 million$0.08 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Breeze Holdings Acquisition Corp. stock logo
BREZ
Breeze Holdings Acquisition
N/AN/AN/AN/AN/A
Clene Inc. stock logo
CLNN
Clene
N/AN/AN/AN/AN/A
Longevity Acquisition Co. stock logo
LOAC
Longevity Acquisition
N/AN/AN/AN/AN/A
Roth CH Acquisition II Co. stock logo
ROCC
Roth CH Acquisition II
N/AN/AN/AN/AN/A
Tottenham Acquisition I Limited stock logo
TOTA
Tottenham Acquisition I
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Breeze Holdings Acquisition Corp. stock logo
BREZ
Breeze Holdings Acquisition
N/A
0.03
0.03
Clene Inc. stock logo
CLNN
Clene
N/A
1.36
1.36
Longevity Acquisition Co. stock logo
LOAC
Longevity Acquisition
0.36
0.10
0.10
Roth CH Acquisition II Co. stock logo
ROCC
Roth CH Acquisition II
0.54
0.71
0.71
Tottenham Acquisition I Limited stock logo
TOTA
Tottenham Acquisition I
N/A
0.12
0.12
CompanyEmployeesShares OutstandingFree FloatOptionable
Breeze Holdings Acquisition Corp. stock logo
BREZ
Breeze Holdings Acquisition
44.30 million1.75 millionNot Optionable
Clene Inc. stock logo
CLNN
Clene
1008.27 million5.35 millionOptionable
Longevity Acquisition Co. stock logo
LOAC
Longevity Acquisition
N/A2.63 millionN/ANot Optionable
Roth CH Acquisition II Co. stock logo
ROCC
Roth CH Acquisition II
N/A41.56 million20.04 millionNot Optionable
Tottenham Acquisition I Limited stock logo
TOTA
Tottenham Acquisition I
N/A3.46 millionN/ANot Optionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Breeze Holdings Acquisition stock logo

Breeze Holdings Acquisition NASDAQ:BREZ

Breeze Holdings Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the defense technology industry. The company was incorporated in 2020 and is based in Irving, Texas. Breeze Holdings Acquisition Corp operates as a subsidiary of Breeze Sponsor, LLC.

Clene stock logo

Clene NASDAQ:CLNN

$3.77 +0.07 (+1.89%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$3.75 -0.02 (-0.53%)
As of 07/16/2025 06:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company also develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, it markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.

Longevity Acquisition stock logo

Longevity Acquisition NASDAQ:LOAC

Longevity Acquisition Corporation does not have significant operations. The company focuses on acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing of assets, entering into contractual arrangements, or other business combination with one or more businesses. Longevity Acquisition Corporation was founded in 2018 and is based in Shanghai, the People's Republic of China.

Roth CH Acquisition II stock logo

Roth CH Acquisition II NASDAQ:ROCC

Roth CH Acquisition II Co. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was formerly known as Roth Acquisition I Co. Roth CH Acquisition II Co. was incorporated in 2019 and is based in Newport Beach, California.

Tottenham Acquisition I stock logo

Tottenham Acquisition I NASDAQ:TOTA

Tottenham Acquisition I Limited does not have significant operations. The company intends to enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It focuses on the technology, media, telecom, education, e-commerce, health-care, and consumer goods industries with primary operations in Asia. The company was founded in 2017 and is based in Central, Hong Kong.